(12-199) Medication Use Evaluation of Success Rates in Nonmedical Switching from the Originator Biologic, Adalimumab, to a Biosimilar in Patients with Established Rheumatic Conditions
Wednesday, December 11, 2024
2:00 PM – 3:00 PM
Location: Hall G, Lower Level
Category: Research-in-Progress Topic: Drug Information/Drug Use Evaluation
Co-Author(s): Emily Acheson, Svetlana Lyamkin, Lisa Herber, Alexis Mod
